Feature article - CPHI report: Get ready sooner
A new CPHI report highlights a significant shift in the pharma outsourcing market
ECHA: Authorisation has positive impacts
The need to obtain REACH authorisation before using harmful chemicals “has sped up substitution and reduced risks to people’s health and the environment - at a reasonable cost”, according to a recent study by ECHA that was based on information from 2010-20.
